keyword
https://read.qxmd.com/read/38649937/photocoagulation-or-sham-laser-in-addition-to-conventional-anti-vegf-therapy-in-macular-edema-associated-with-telcaps-due-to-diabetic-macular-edema-or-retinal-vein-occlusion-taladme-a-study-protocol-for-a-multicentric-french-two-group-non-commercial-active
#1
JOURNAL ARTICLE
Bénédicte Dupas, Daniela Castro-Farias, Jean-François Girmens, Ali Eginay, Aude Couturier, Frederic Villeroy, Marie-Noëlle Delyfer, Catherine Creuzot-Garcher, Audrey Giocanti-Auregan, Laurence Béral, Carl Arndt, Charles Mesnard, Eric Vicaut, Philippe Chaumet-Riffaud, Isabelle Durand-Zaleski, Michel Paques
BACKGROUND: Macular edema (ME) results from hyperpermeability of retinal vessels, leading to chronic extravasation of plasma components into the retina and hence potentially severe visual acuity loss. Current standard of care consists in using intravitreal injections (IVI), which results in a significant medical and economic burden. During diabetic retinopathy (DR) or retinal vein occlusion (RVO), it has recently been shown that focal vascular anomalies (capillary macro-aneurysms, also termed TelCaps) for telangiectatic capillaries may play a central role in the onset, early recurrence, and/or persistence of ME...
April 22, 2024: Trials
https://read.qxmd.com/read/38648434/optical-coherence-tomography-biomarkers-drol-pros-snd-hyperreflective-walls-of-foveal-cystoid-spaces-as-predictors-of-central-macular-thickness-and-visual-acuity-in-diabetic-macular-edema-treated-with-intravitreal-ranibizumab
#2
JOURNAL ARTICLE
Ayushi Sardana, Kamaljeet Singh, Arti Singh, Vinod K Singh
PURPOSE: This study aims to establish DROL (disruption of retinal outer layers), PROS (photoreceptor outer segment length), SND (subfoveal neuroretinal detachment), and hyperreflective walls of foveal cystoid spaces (HRW) as optical coherence tomography (OCT) biomarkers and predictors of central macular thickness (CMT) and visual acuity in diabetic macular edema (DME) treated with intravitreal ranibizumab (IVR). METHODS: In this prospective, interventional study performed at a tertiary care center over a span of 1 year from December 2021 to December 2022, 50 eyes of 46 patients of DME were included...
May 1, 2024: Indian Journal of Ophthalmology
https://read.qxmd.com/read/38638802/evaluation-of-phytoconstituents-in-marigold-effluent-for-their-antifungal-activity-against-plant-pathogens
#3
JOURNAL ARTICLE
Tulja Sanam, Umashankar Nagaraju, Benherlal P S, Sridhar Goud Nerella, Jayaramaiah R, Kadalli G G, Satya Srii V
The current study placed an intense emphasis on the excess discharge of agro-based industrial effluent and the use of plant extract antimicrobials to inhibit the growth of pathogens in crop plants. An effluent (treated and untreated) from the marigold flower processing industry has been identified for the presence of volatile and semi-volatile organic compounds, and a total of 18 in treated effluent and 23 in untreated effluent were found using gas chromatography-mass spectrometry. A total of 13 classes were identified, which include carboxylic acid, phenols, esters, alkanes, alkenes, alcohols, cyanide, heterocyclic, flavonoids, aldehydes, polycyclic aromatic, cycloalkanes, and cycloalkenes...
2024: Front Fungal Biol
https://read.qxmd.com/read/38638593/the-influence-of-obesity-on-outcomes-following-arthroscopic-rotator-cuff-repair-a-systematic-review-and-meta-analysis-of-118-331-patients-internationally
#4
JOURNAL ARTICLE
Alexis B Sandler, Clare K Green, John P Scanaliato, Austin B Fares, John C Dunn, Nata Parnes
BACKGROUND: Given the rising prevalence of obesity, the number of patients with obesity undergoing arthroscopic rotator cuff repair (RCR) will likely increase; however, there have been mixed results in the existing literature with regard to the effect of elevated body mass index (BMI) on functional outcomes and complications. METHODS: The patient-reported outcome measures included the visual analog scale (VAS) pain score, the American Shoulder and Elbow Surgeons (ASES) score, range of motion, and adverse events...
2024: JB & JS Open Access
https://read.qxmd.com/read/38632841/post-pandemic-changes-to-employment-and-employment-satisfaction-in-early-career-and-career-advancing-athletic-trainers
#5
JOURNAL ARTICLE
Nicolette A Harris, Emily K Mulkey, Sanam Rezazadeh, Matthew C Smitley, Alicia M Montalvo
CONTEXT: The labor market suffered a mass exodus of employees, including healthcare workers, due to the COVID-19 pandemic. Previous research highlights the vulnerability of young professional athletic trainers (YPATs) to attrition. Investigating pandemic-related employment changes and their impact is essential for developing strategies to improve the retention of YPATs. OBJECTIVE: to determine impact of COVID-19 on YPATs' employment and effect of COVID-19 and employment setting migration on outcome measures of personal and financial well-being, job and career satisfaction, and optimism about staying in the profession...
April 18, 2024: Journal of Athletic Training
https://read.qxmd.com/read/38621369/effect-of-pro-re-nata-regimen-with-anti-vegf-on-type-3-macular-neovascularization-long-term-outcomes
#6
JOURNAL ARTICLE
Lisa Toto, Pasquale Viggiano, Alberto Quarta, Mariaoliva Grassi, Chiara De Nicola, Raffaella Aloia, Rossella D'Aloisio, Giacomo Boscia, Francesco Boscia, Annamaria Porreca, Marta Di Nicola, Maria Cristina Savastano, Rodolfo Mastropasqua
UNLABELLED: (348 words) Introduction: The purpose of this study is to investigate long-term outcomes of intravitreal injections (IVI) of anti-vascular endothelial growth factor (VEGF) in neovascular age-related macular degeneration (nAMD) with type 3 macular neovascularization (MNV). METHODS: This retrospective study included 19 eyes of 17 patients with nAMD and type 3 MNV treated with anti-VEGF IVI with a loading dose and PRN regimen. Best corrected visual acuity (BCVA), central macular thickness (CMT), presence of macular intraretinal fluid (IRF) and subretinal fluid (SRF), flow area (FA), subfoveal choroidal thickness (CT) and macular atrophy (MA) were assessed at baseline (T0) and during follow up (T1, post loading phase; T2, one year; T3, two years, T4>2 years)...
April 15, 2024: Ophthalmic Research
https://read.qxmd.com/read/38615818/one-year-anti-vegf-therapy-outcomes-in-diabetic-macular-edema-based-on-treatment-intensity-data-from-the-frb-registry
#7
JOURNAL ARTICLE
Hemal Mehta, Pierre-Henry Gabrielle, Yohei Hashimoto, Getiye Dejenu Kibret, Jennifer Arnold, Tremeur Guillaumie, Wajiha Jurdi Kheir, Gerhard Kok, Stela Vujosevic, Louise O'Toole, Els Mangelschots, Nandor Jaross, Lala Ceklic, Vincent Daien, Francesco Viola, David Squirrell, Francisco Javier Lavid, Catherine Creuzot-Garcher, Daniel Barthelmes, Mark Gillies
PURPOSE: To compare one-year outcomes of eyes with diabetic macular edema (DME) treated in routine clinical practice based on the proportion of visits where intravitreal vascular endothelial growth factor (VEGF) inhibitor injections were delivered. DESIGN: Cohort study PARTICIPANTS: There were 2288 treatment-naïve eyes with DME starting intravitreal VEGF inhibitor therapy from 31 October 2015 to 31 October 2021 from the Fight Retinal Blindness! international outcomes registry...
April 12, 2024: Ophthalmology Retina
https://read.qxmd.com/read/38615056/racial-disparities-with-prn-medication-usage-in-inpatient-psychiatric-treatment
#8
JOURNAL ARTICLE
Areef S Kassam, Peter Karalis, Taline Aydinian, Anita Panjwani, Gabriel Martinez, Aaron Whiteman, Magdoline Daas, E Ann Cunningham
Racial disparities in psychiatric diagnoses and treatment have significant public health implications, contributing to inequities in healthcare outcomes. We specifically examined racial disparities regarding pro re nata (PRN), or as needed, medications. Data from 14,616 encounters across 2019-2020 within Community Health Network's inpatient psychiatric setting in Indianapolis, Indiana were included in this study. Due to the demographic sample size, analyses were narrowed to Black and White patients. Primary outcomes included comparisons across race for all PRN administrations and PRN administrations of antipsychotics vs...
April 13, 2024: Schizophrenia (Heidelb)
https://read.qxmd.com/read/38596158/comparison-of-pain-management-strategies-to-reduce-opioid-use-postoperatively-in-free-flap-breast-reconstruction-pain-catheter-versus-nerve-block-in-addition-to-refinements-in-the-oral-pain-management-regime
#9
JOURNAL ARTICLE
Andrea B Stefansdottir, Luis Vieira, Arni Johnsen, Daniel Isacson, Andres Rodriguez, Maria Mani
Background  Perioperative management in autologous breast reconstruction has gained focus in recent years. This study compares two pain management protocols in patients undergoing abdominal-based free flap breast reconstruction: a past protocol (PP) and a current protocol (CP)-both intended to reduce opioid consumption postoperatively. The PP entails use of a pain catheter in the abdominal wound and the CP consists of an intraoperative nerve block in addition to refinements in the oral pain management...
March 2024: Archives of Plastic Surgery
https://read.qxmd.com/read/38589960/clinical-effects-of-atorvastatin-combined-with-conbercept-in-the-treatment-of-patients-with-macular-edema-secondary-to-retinal-vein-occlusion-and-carotid-plaque-study-protocol-for-a-prospective-randomized-controlled-trial
#10
JOURNAL ARTICLE
Bangtao Yao, Bei Wang, Jun Yang, Yan Geng, Hao Yu, Yuhui Liu, Gang Liu, Xiuying Wang
INTRODUCTION: Intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) drugs have been widely used in patients with macular edema (ME) secondary to retinal vein occlusion (RVO); however, recurrence is a major concern. This study aims to observe the clinical effects of atorvastatin and intravitreal therapy in the treatment of patients with branch or central RVO-ME and coexistent carotid plaques (CP). METHODS AND ANALYSIS: A prospective randomized controlled clinical trial will be conducted...
April 8, 2024: Trials
https://read.qxmd.com/read/38588051/n%C3%AE-acetyltransferase-naa50-mediates-plant-immunity-independent-of-the-n%C3%AE-acetyltransferase-a-complex
#11
JOURNAL ARTICLE
Laura Armbruster, Marlena Pożoga, Zhongshou Wu, Jürgen Eirich, Karen Thulasi Devendrakumar, Carolina De La Torre, Pavlina Miklánková, Monika Huber, Fabian Bradic, Gernot Poschet, Jonas Weidenhausen, Sabine Merker, Thomas Ruppert, Carsten Sticht, Irmgard Sinning, Iris Finkemeier, Xin Li, Rüdiger Hell, Markus Wirtz
In humans and plants, 40% of the proteome is co-translationally acetylated at the N-terminus by a single Nα-acetyltransferase (Nat) termed NatA. The core NatA complex is comprised of the catalytic subunit Nα- acetyltransferase 10 (NAA10) and the ribosome-anchoring subunit NAA15. The regulatory subunit Huntingtin Yeast Partner K (HYPK) and the acetyltransferase NAA50 join this complex in humans. Even though both are conserved in Arabidopsis (Arabidopsis thaliana), only AtHYPK is known to interact with AtNatA...
April 8, 2024: Plant Physiology
https://read.qxmd.com/read/38555008/real-life-experience-of-dexamethasone-implant-under-a-proactive-treatment-regimen-the-prodex-study
#12
JOURNAL ARTICLE
Samuel Chacun, Laurent Kodjikian, Cécile Ricard, Sandra Elbany, Violaine Marthelot, Jad Akesbi, François Devin, Carole Burillon, Philippe Denis, Thibaud Mathis
PURPOSE: To assess the effectiveness of switching intravitreal dexamethasone implants (DEX-implant) from pro re nata (PRN) treatment regimen to a proactive regimen in patients with macular edema of diverse etiologies. DESIGN: An observational, retrospective, uncontrolled, multicenter, national case series. PARTICIPANTS: Eighty-one eyes from 68 patients treated between October 2015 and June 2023 were included. METHODS: This study included consecutive eyes treated with DEX-implant who were switched from a PRN regimen to a proactive regimen, for diabetic macular edema (DME), retinal vein occlusion (RVO), non-infectious uveitis macular edema (UME; including post-surgical macular edema), and radiation maculopathy (RM)...
March 28, 2024: Ophthalmology Retina
https://read.qxmd.com/read/38551696/pro-re-nata-anti-vegf-treatment-in-pachychoroid-neovasculopathy-compared-with-age-related-macular-degeneration-based-on-optical-coherence-tomography
#13
JOURNAL ARTICLE
Güner Üney, Dicle Hazırolan, Nurten Ünlü, Özlem Candan
PURPOSE: To compare anti-vascular endothelial growth factor (anti-VEGF) treatment in pachychoroid neovasculopathy (PNV) and age related macular degeneration (AMD). METHODS: Cases having pro re nata (PRN) anti-VEGF treatment for choroidal neovascularization were reviewed and grouped as PNV and AMD. Groups were compared according to central foveal thickness (CFT), best corrected visual acuity (BCVA), and total injection over 12 months. The correlation of beginning choroidal thickness, CFT, and BCVA with final BCVA was analyzed...
March 29, 2024: International Ophthalmology
https://read.qxmd.com/read/38530653/national-athletic-trainers-association-bridge-statement-management-of-sport-related-concussion
#14
JOURNAL ARTICLE
Steven P Broglio, Johna K Register-Mihalik, Kevin M Guskiewicz, John J Leddy, Alejandra Merriman, Tamara C Valovich McLeod
OBJECTIVE: To provide athletic trainers and team physicians with updated recommendations to the 2014 National Athletic Trainers' Association (NATA) concussion position statement regarding concussion management, specifically in the areas of education, assessment, prognostic factors, mental health, return to academics, physical activity, rest, treatment, and return to sport. BACKGROUND: Athletic trainers have benefited from the 2 previous NATA position statements on concussion management, and although the most recent NATA position statement is a decade old, knowledge gains in the medical literature warrant updating several (but not all) recommendations...
March 1, 2024: Journal of Athletic Training
https://read.qxmd.com/read/38494487/preserving-visual-acuity-a-compelling-12-year-case-study-of-controlling-neovascular-age-related-macular-degeneration
#15
JOURNAL ARTICLE
Rita O Tomás, António Campos, Nuno Oliveira, Pedro Soares, João P Sousa
INTRODUCTION: In neovascular age-related macular degeneration (nAMD) trials, anti-VEGF injection frequency decreases after the first year, while outcomes remain primarily related to the number of injections. To the best of our knowledge, there are no reports of maintaining the best corrected visual acuity (BCVA) for more than 7 years in extension studies. OBJECTIVE: To report a 12-year follow-up of a real-world case of nAMD where BCVA was preserved from declining...
March 18, 2024: BMC Ophthalmology
https://read.qxmd.com/read/38494130/five-year-clinical-trial-of-low-concentration-atropine-for-myopia-progression-lamp-study-phase-4-report
#16
JOURNAL ARTICLE
Xiu Juan Zhang, Yuzhou Zhang, Benjamin H K Yip, Ka Wai Kam, Fangyao Tang, Xiangtian Ling, Mandy P H Ng, Alvin L Young, Pei-Chang Wu, Clement C Tham, Li Jia Chen, Chi Pui Pang, Jason C Yam
PURPOSE: To evaluate (1) the long-term efficacy of low-concentration atropine over 5 years, (2) the proportion of children requiring retreatment and associated factors (3) the efficacy of pro re nata (PRN) retreatment using 0.05% atropine from year 3 to 5. DESIGN: A randomized, double-masked extended trial. METHODS: Children aged 4-12 years originally from the Low-Concentration Atropine for Myopia Progression study were followed up for 5 years...
March 15, 2024: Ophthalmology
https://read.qxmd.com/read/38483688/can-objective-parameters-in-optical-coherence-tomography-be-useful-markers-in-the-treatment-and-follow-up-of-type-1-and-type-2-macular-neovascularizations-related-to-neovascular-age-related-macular-degeneration
#17
JOURNAL ARTICLE
Osman Özen, Ayşe Gül Koçak Altıntaş
PURPOSE: The aim of this study was to compare the responses of type 1 and type 2 macular neovascularizations (MNV) caused by neovascular type age-related macular degeneration (n-AMD) to intravitreal anti-vascular endothelial growth factor (VEGF) treatments using quantitative parameters determined by optical coherence tomography (OCT). Additionally, it was also intended to assess the connections between these quantitative parameters and changes in best-corrected visual acuity (BCVA) and the number of intravitreal anti-VEGF injections required within a year...
March 14, 2024: International Ophthalmology
https://read.qxmd.com/read/38462934/prevalence-and-characteristics-of-patients-prescribed-opioids-and-central-nervous-system-depression-agents-on-discharge-to-hospice-care
#18
JOURNAL ARTICLE
Cindy T Nguyen, Mary Lynn McPherson, Brie N Noble, Jon P Furuno
BACKGROUND: Hospice patients with end-stage liver disease (ESLD) have an increased risk of adverse drug events due to physiological changes and changes in pharmacokinetic and pharmacodynamic properties of medications; however, the use of opioid and central nervous system (CNS) depressant prescribing among patients with ESLD is prevalent. This study quantified the frequency and distribution of opioid and concomitant respiratory and CNS depressant prescribing among hospice patients with ESLD compared to other common hospice diagnoses of cancer, chronic obstructive pulmonary disorder (COPD), heart failure, and end-stage renal disease...
March 6, 2024: Annals of Palliative Medicine
https://read.qxmd.com/read/38458571/mesoporous-zinc-oxide-based-drug-delivery-system-offers-an-antifungal-and-immunoregulatory-strategy-for-treating-keratitis
#19
JOURNAL ARTICLE
Lingwen Gu, Jing Lin, Qian Wang, Fanyue Meng, Geng Niu, Hao Lin, Menghui Chi, Zhuhui Feng, Hengrui Zheng, Daohao Li, Guiqiu Zhao, Cui Li
Fungal keratitis is a refractory eye disease that is prone to causing blindness. Fungal virulence and inflammatory responses are two major factors that accelerate the course of fungal keratitis. However, the current antifungal drugs used for treatment usually possess transient residence time on the ocular surface and low bioavailability deficiencies, which limit their therapeutic efficacy. In this work, natamycin (NATA)-loaded mesoporous zinc oxide (Meso-ZnO) was synthesized for treating Aspergillus fumigatus keratitis with excellent drug-loading and sustained drug release capacities...
March 6, 2024: Journal of Controlled Release
https://read.qxmd.com/read/38438829/cost-effectiveness-of-faricimab-in-the-treatment-of-diabetic-macular-oedema-dmo-a-uk-analysis
#20
JOURNAL ARTICLE
Christian Bührer, Thomas Paling, Richard Gale, Tatiana Paulo, Marloes Bagijn
AIM: The aim of this work was to evaluate the cost-effectiveness of faricimab against relevant therapeutic alternatives used in clinical practice for the treatment of diabetic macular oedema (DMO) in the UK. METHODS: A state-transition (Markov) model, with health states based on visual acuity scores and treatment pathways, was developed to conduct cost-utility analysis of faricimab treat and extend (T&E) regimen versus ranibizumab pro re nata (PRN) and aflibercept PRN over a time horizon of 25 years...
March 4, 2024: PharmacoEconomics Open
keyword
keyword
81148
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.